Department of Otolaryngology-Head and Neck Surgery, Baltimore, Maryland, USA.
Laryngoscope. 2013 Jul;123(7):1660-9. doi: 10.1002/lary.23975. Epub 2013 Jun 3.
OBJECTIVES/HYPOTHESIS: The Centers for Medicare and Medicaid Services has identified 10 hospital-acquired conditions (HACs) for which they will not reimburse care. We sought to determine the incidence of HACs in head and neck cancer (HNCA) surgery and the association with in-hospital mortality, complications, length of hospitalization, and costs.
Retrospective cross-sectional study.
Discharge data from the Nationwide Inpatient Sample for 123,662 patients who underwent an ablative procedure for a malignant oral cavity, laryngeal, hypopharyngeal, or oropharyngeal neoplasm during 2001-2008 were analyzed using cross-tabulations and multivariate regression modeling.
HACs occurred in <1% of cases, with vascular catheter-associated infection comprising >70% of all HACs. The occurrence of HACs was significantly associated with urgent or emergent admission (odds ratio [OR]=2.0, P=.004), major surgical procedures (OR=2.3, P<.001), flap reconstruction (OR=3.5, P<.001), and advanced comorbidity (OR=2.0, P<.001). There was no association between HACs and hospital size, location, ownership, volume status, or safety-net burden. HACs were significantly associated with in-hospital mortality (OR=3.8, P=.001), surgical complications (OR=4.9, P<.001), and medical complications (OR=5.6, P<.001). After controlling for all other variables, HACs were associated with significantly increased length of hospitalization and hospital-related costs, with vascular catheter-associated infection and foreign object after surgery associated with the greatest increase in length of stay and costs.
HACs are uncommon events in HNCA surgical patients. Because prediction of HACs is poor and the potential for human error crosses demographic, geographic, and structural boundaries, universal innovative measures to reduce the occurrence of HACs are needed.
目的/假设:医疗保险和医疗补助服务中心已经确定了 10 种医院获得性疾病(HAC),他们将不会为此类疾病的治疗提供报销。我们旨在确定头颈部癌症(HNCA)手术中 HAC 的发生率,以及其与住院死亡率、并发症、住院时间和费用的关联。
回顾性横断面研究。
利用交叉表和多变量回归模型,对 2001 年至 2008 年间全国住院患者样本中 123662 例行恶性口腔、喉、下咽或口咽肿瘤切除术患者的出院数据进行分析。
不到 1%的病例发生 HAC,其中血管导管相关感染占所有 HAC 的 70%以上。HAC 的发生与紧急或紧急入院(优势比[OR] = 2.0,P=.004)、大手术(OR = 2.3,P<.001)、皮瓣重建(OR = 3.5,P<.001)和严重合并症(OR = 2.0,P<.001)显著相关。HAC 与医院规模、位置、所有权、容量状态或安全网负担之间没有关联。HAC 与住院死亡率(OR = 3.8,P=.001)、手术并发症(OR = 4.9,P<.001)和医疗并发症(OR = 5.6,P<.001)显著相关。在控制所有其他变量后,HAC 与住院时间和医院相关费用显著增加相关,血管导管相关感染和术后异物与住院时间和费用增加的相关性最大。
HNCA 手术患者中 HAC 是罕见事件。由于 HAC 的预测不佳,且人为错误可能跨越人口统计学、地理和结构边界,因此需要采取普遍的创新措施来降低 HAC 的发生。